MYL9 Antikörper (C-Term)
Kurzübersicht für MYL9 Antikörper (C-Term) (ABIN953573)
Target
Alle MYL9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 95-125, C-Term
-
Spezifität
- This antibody recognizes human MYL9 at C-term.
-
Aufreinigung
- Purified through a Protein A column followed by peptide affinity purification
-
Immunogen
- Synthetic peptide - KLH conjugated - corresponding to the C-terminal region (between 95-125aa) of human MYL9
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- MYL9 (Myosin Regulatory Light Polypeptide 9 (MYL9))
-
Andere Bezeichnung
- MYL9
-
Hintergrund
- Myosin, a structural component of muscle, consists of two heavy chains and four light chains. The protein encoded by the MYL9 gene is a myosin light chain that may regulate muscle contraction by modulating the ATPase activity of myosin heads. The encoded protein binds calcium and is activated by myosin light chain kinase, Two transcript variants encoding different isoforms have been found.Synonyms: LC20, MLC-2C, MLC2, MRLC1, MYRL2, Myosin RLC, Myosin regulatory light chain 2, Myosin regulatory light chain MRLC1, Myosin regulatory light polypeptide 9, smooth muscle
-
Molekulargewicht
- 19827 Da
-
Gen-ID
- 10398
-
NCBI Accession
- NP_006088
Target
-